Team:Tec-Monterrey/safetypage
From 2011.igem.org
(Difference between revisions)
(49 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
<html xmlns="http://www.w3.org/1999/xhtml"><head> | <html xmlns="http://www.w3.org/1999/xhtml"><head> | ||
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
+ | |||
+ | |||
<title>wiki</title> | <title>wiki</title> | ||
<style type="text/css"> | <style type="text/css"> | ||
<!-- | <!-- | ||
#top-section { | #top-section { | ||
- | + | height: 100px; | |
- | + | ||
border: none; | border: none; | ||
height:20px | height:20px | ||
Line 44: | Line 45: | ||
border-left: 0 solid; | border-left: 0 solid; | ||
border-right: 0 solid; | border-right: 0 solid; | ||
- | width: | + | } |
+ | #content{ | ||
+ | width: 80%; | ||
} | } | ||
Line 57: | Line 60: | ||
.firstHeading { | .firstHeading { | ||
display: none;} | display: none;} | ||
- | |||
body { | body { | ||
font: 12px Tahoma, Geneva, sans-serif; | font: 12px Tahoma, Geneva, sans-serif; | ||
- | background-image: url(https://static.igem.org/mediawiki/2011/ | + | background-image: url(https://static.igem.org/mediawiki/2011/4/43/Lefondoleposter.png); |
+ | background-repeat:no-repeat; | ||
+ | background-size: 100%; | ||
margin: 0; | margin: 0; | ||
padding: 0; | padding: 0; | ||
Line 83: | Line 87: | ||
} | } | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
a:link { | a:link { | ||
Line 101: | Line 102: | ||
.container { | .container { | ||
- | width: | + | width: 100%; |
max-width: 1260px; | max-width: 1260px; | ||
min-width: 780px; | min-width: 780px; | ||
Line 111: | Line 112: | ||
.sidebar1 { | .sidebar1 { | ||
float: left; | float: left; | ||
- | width: | + | width: 15%; |
- | + | padding-bottom: 10px; | |
background-color:#04191d; | background-color:#04191d; | ||
+ | -moz-border-radius: 8px; | ||
+ | -webkit-border-radius: 8px; | ||
} | } | ||
Line 134: | Line 137: | ||
border-top:none; | border-top:none; | ||
margin-bottom: 15px; | margin-bottom: 15px; | ||
+ | |||
} | } | ||
+ | ul.nav li { | ||
+ | border-bottom: 0px solid #04191d; | ||
+ | |||
+ | } | ||
ul.nav a, ul.nav a:visited { | ul.nav a, ul.nav a:visited { | ||
Line 145: | Line 153: | ||
} | } | ||
ul.nav a:hover, ul.nav a:active, ul.nav a:focus { | ul.nav a:hover, ul.nav a:active, ul.nav a:focus { | ||
- | background: # | + | background: #339dff; /*float amarillo*/ |
color: #FFF; | color: #FFF; | ||
} | } | ||
- | + | .frame { | |
+ | font:12px arial; | ||
+ | width:700; | ||
+ | height:350; | ||
+ | max-height: 350px; | ||
+ | border:none; | ||
+ | overflow:auto; | ||
+ | border:0px solid black; | ||
+ | padding:5; | ||
+ | } | ||
.fltrt { | .fltrt { | ||
float: right; | float: right; | ||
Line 180: | Line 197: | ||
} | } | ||
+ | |||
+ | table { | ||
+ | background: none repeat scroll 0 0 transparent} | ||
Line 191: | Line 211: | ||
-moz-border-radius: 3px; | -moz-border-radius: 3px; | ||
-webkit-border-radius: 3px; | -webkit-border-radius: 3px; | ||
- | border-bottom: 0px solid #04191d; | + | border-bottom: 0px solid #04191d; |
} | } | ||
Line 197: | Line 217: | ||
/* panel heading on rollover */ | /* panel heading on rollover */ | ||
.panel h2:hover, .panelcollapsed h2:hover { | .panel h2:hover, .panelcollapsed h2:hover { | ||
- | background-color: # | + | background-color: #339dff; |
color: #FFF; | color: #FFF; | ||
} | } | ||
Line 208: | Line 228: | ||
background-position: 280px; | background-position: 280px; | ||
} | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
/* panel content - do not set borders or paddings */ | /* panel content - do not set borders or paddings */ | ||
Line 219: | Line 234: | ||
overflow: hidden; | overflow: hidden; | ||
font-size: 14px; | font-size: 14px; | ||
- | |||
- | |||
} | } | ||
Line 226: | Line 239: | ||
.panelcollapsed .panelcontent { display: none; } | .panelcollapsed .panelcontent { display: none; } | ||
+ | --> | ||
+ | </style><!--[if lte IE 7]> | ||
+ | <style> | ||
+ | .content { margin-right: -1px; } | ||
+ | ul.nav a { zoom: 1; } | ||
+ | </style> | ||
+ | <![endif]--> | ||
+ | <script type="text/javascript"> | ||
+ | <!-- | ||
+ | i = 0 | ||
+ | var speed = 10 | ||
- | + | function scrollDown() { | |
- | + | i = i + speed | |
- | { | + | var div = document.getElementById("frame1") |
- | + | div.scrollTop = i | |
- | + | if (i > div.scrollHeight - 300) {i = 350} | |
- | + | t1=setTimeout("scrollDown()",100) | |
- | + | ||
- | - | + | |
- | + | ||
} | } | ||
- | + | function scrollUp() { | |
- | + | i = i - speed | |
- | + | var div = document.getElementById("frame1") | |
- | . | + | div.scrollTop = i |
- | + | if (i < 0) {i = 0} | |
- | + | t1=setTimeout("scrollUp()",100) | |
- | + | ||
} | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 295: | Line 281: | ||
var PANEL_COLLAPSED_CLASS = "panelcollapsed"; | var PANEL_COLLAPSED_CLASS = "panelcollapsed"; | ||
var PANEL_HEADING_TAG = "h2"; | var PANEL_HEADING_TAG = "h2"; | ||
- | |||
var PANEL_CONTENT_CLASS = "panelcontent"; | var PANEL_CONTENT_CLASS = "panelcontent"; | ||
var PANEL_COOKIE_NAME = "panels"; | var PANEL_COOKIE_NAME = "panels"; | ||
Line 306: | Line 291: | ||
// get all headings | // get all headings | ||
- | var | + | var headingTags = document.getElementsByTagName(PANEL_HEADING_TAG); |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
// go through all tags | // go through all tags | ||
Line 395: | Line 362: | ||
var direction = (!expanding ? -1 : 1); | var direction = (!expanding ? -1 : 1); | ||
+ | if (direction > 0) | ||
+ | collapseAll(); | ||
setTimeout(function(){animateStep(panelContent,1,stepHeight,direction)}, PANEL_ANIMATION_DELAY); | setTimeout(function(){animateStep(panelContent,1,stepHeight,direction)}, PANEL_ANIMATION_DELAY); | ||
} | } | ||
- | + | /** | |
+ | * Change the height of the target | ||
+ | * @param panelContent reference to the panel content to change height | ||
+ | * @param iteration current iteration; animation will be stopped when iteration reaches PANEL_ANIMATION_STEPS | ||
+ | * @param stepHeight height increment to be added/substracted in one step | ||
+ | * @param direction 1 for expanding, -1 for collapsing | ||
+ | */ | ||
function animateStep(panelContent, iteration, stepHeight, direction) | function animateStep(panelContent, iteration, stepHeight, direction) | ||
{ | { | ||
Line 509: | Line 484: | ||
<div class="topbar"> | <div class="topbar"> | ||
- | <div style=" | + | <div style="filter:alpha(opacity=70);opacity:.7;"> |
- | + | ||
- | + | ||
- | + | ||
+ | <img src="https://static.igem.org/mediawiki/2011/2/20/Logotec.png" alt="ITESM" name="teclogo" width="146" height="52" id="teclogo"> | ||
<a href="https://2011.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2011/7/73/Logoigemsmall.png" alt="iGEM" name="logoigem" width="70" height="61" id="logoigem"></a> | <a href="https://2011.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2011/7/73/Logoigemsmall.png" alt="iGEM" name="logoigem" width="70" height="61" id="logoigem"></a> | ||
<p> </p> | <p> </p> | ||
Line 542: | Line 516: | ||
<div class="panelcontent" style=""> | <div class="panelcontent" style=""> | ||
- | + | ||
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectoverview">overview</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p> | ||
- | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling"> | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">genetic frame</a></p> |
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults/methods">methods</a></p> | ||
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">results</a></p> | ||
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p> | ||
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectprotocols">protocols</a><p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage">safety</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage">safety</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectnotebook">notebook</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectnotebook">notebook</a></p> | ||
- | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/ | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sampledata">sample data</a></p> |
</div> | </div> | ||
</div> | </div> | ||
Line 559: | Line 538: | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/teammembers">members</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teammembers">members</a></p> | ||
- | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teaminstallations"> | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teaminstallations">headquarters</a></p> |
- | + | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/microcongreso">micro congress</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/microcongreso">micro congress</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamfriends">friends</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamfriends">friends</a></p> | ||
Line 566: | Line 544: | ||
</div> | </div> | ||
</div> | </div> | ||
- | </li><li> | + | </li> |
+ | <li> | ||
<div class="panelcollapsed"> | <div class="panelcollapsed"> | ||
- | + | <h2>EXTRAS</h2> | |
- | + | ||
- | + | ||
<div class="panelcontent"> | <div class="panelcontent"> | ||
- | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sitemap">site map</a></p> | |
- | + | ||
- | + | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsplatinum">sponsors platinum</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsplatinum">sponsors platinum</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsgold">sponsors gold</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsgold">sponsors gold</a></p> | ||
Line 580: | Line 555: | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/specialthanks">special thanks</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/specialthanks">special thanks</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/followus">follow us!</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/followus">follow us!</a></p> | ||
- | + | </div> | |
- | + | </div> | |
- | + | ||
</li> | </li> | ||
</ul> | </ul> | ||
Line 589: | Line 563: | ||
<div class="content"> | <div class="content"> | ||
- | + | <div style=" | |
- | + | text-align:center;"> | |
- | + | <a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage"><img src="https://static.igem.org/mediawiki/2011/3/3d/Safetyqa01.png" > </a> | |
- | + | <a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage/qanda"> | |
- | + | <img src="https://static.igem.org/mediawiki/2011/d/d6/Biosafty01.png"> </a> | |
- | + | ||
- | + | <!--in sub pages, this divisions should be comments! :D--> | |
- | + | <div style=" | |
- | background- | + | padding:25px 50px; |
- | color:# | + | background-color:#04191d; |
+ | color:#333; | ||
+ | text-align:left; | ||
+ | margin:5px 30px; | ||
"> | "> | ||
- | + | ||
- | + | </head> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | <body> | ||
+ | <div align="justify"> | ||
+ | <div style="-moz-border-radius: 4px;-webkit-border-radius: 4px;"> | ||
+ | <div class="frame" id="frame1" style="background-color:#e5e5e5;"> | ||
+ | <br> | ||
+ | <a href=""><img src="https://static.igem.org/mediawiki/2011/7/78/Qainfo.png" width="300" height="50"> </a> | ||
- | </div></div></body></html> | + | |
+ | |||
+ | <p class="textojustif"> | ||
+ | <br> | ||
+ | 1. Would the materials used in your project and/or your final | ||
+ | product | ||
+ | pose: | ||
+ | <br><br> | ||
+ | a. Risks to the safety and health of team members or others in the | ||
+ | <br><br> | ||
+ | The biological device in which we worked on this project doesn’t pose | ||
+ | a risk to any of the team members’ health if correctly handled, however we | ||
+ | should always consider that they carry an antibiotic resistance. | ||
+ | Nevertheless, we must also take in mind the chemicals employed | ||
+ | in the methods used for the completion of this project. In order to dispose | ||
+ | any of those hazardous substances, besides following the General Safety | ||
+ | Regulations of the Laboratory, we also followed the Safety Regulations of | ||
+ | Centro de Biotecnología FEMSA. For example, in agarose gel electrophoresis | ||
+ | ethidium bromide and SYBR green are commonly used; in this case, we | ||
+ | followed a protocol for handling and disposal of the chemicals, placing objects | ||
+ | contaminated with it in special containers. In the case of pipette tips, those | ||
+ | were treated with benzal and sterilized by autoclave. These measures were | ||
+ | done to avoid direct contact between team members and hazardous material. | ||
+ | <br><br> | ||
+ | b. Risks to the safety and health of the general public if released | ||
+ | by design or accident? | ||
+ | <br><br> | ||
+ | Concerning the risks to people in general, the most dangerous | ||
+ | problem we observed is the exposure to microorganisms that are resistant to | ||
+ | antibiotics, posing a threat on the treatment of many diseases. For this | ||
+ | reason, we concealed our bacteria for lab use only following the appropriate | ||
+ | measures for handling and disposing them, such as sterilizing the tubes and | ||
+ | dishes containing modified bacteria after using them. Regarding chemical | ||
+ | substances, we assured that every chemical used was properly disposed, | ||
+ | even gloves used by the team when they made contact with any hazardous | ||
+ | substance, to make sure no people alien to the lab could be exposed to the | ||
+ | chemicals. | ||
+ | <br><br> | ||
+ | c. Risks to environmental quality if released by design or | ||
+ | accident? | ||
+ | <br><br> | ||
+ | Our biological devices pose few risks to the environment since | ||
+ | we are using enzymes already present in other bacteria and non-dangerous | ||
+ | substrates and products. However, there is a slight environmental concern | ||
+ | in one of our constructs. This construct employs cellulose as a substrate, | ||
+ | and since all plants have cellulose in their cell wall it is possible that they | ||
+ | could be degraded under unusual circumstances, thus generating a negative | ||
+ | environmental impact. Again, caution measures must be taken in order to | ||
+ | have the modified bacteria concealed so they don’t pose a direct threat to the | ||
+ | environment. | ||
+ | <br><br> | ||
+ | d. Risks to security through malicious misuse by individuals, | ||
+ | groups | ||
+ | or states? | ||
+ | <br><br> | ||
+ | Our project doesn’t have any point of risk in regards of biosecurity. Due | ||
+ | to the nature of the process and the microorganisms involved, the devices do | ||
+ | not cause any hazard that could be misused by individuals, groups or states | ||
+ | to affect people’s security and wellbeing. | ||
+ | <br><br> | ||
+ | Please explain your responses (whether yes or no) to these | ||
+ | questions. | ||
+ | |||
+ | Specifically, are any parts or devices in your project associated | ||
+ | |||
+ | (or known to cause): | ||
+ | <br><br> | ||
+ | - pathogenicity, infectivity, or toxicity? | ||
+ | Neither of our devices has an associated risk in these fields. The only | ||
+ | possible concern could be the EstA protein used in the device, because it is | ||
+ | capable of the production of a toxin when the entire sequence is used; but since | ||
+ | only a partial sequence of this protein is needed in the device (only the | ||
+ | membrane expressing part), the toxin cannot be synthesized and the risk is | ||
+ | therefore eliminated. | ||
+ | <br><br> | ||
+ | - threats to environmental quality? | ||
+ | There is a very little, if none at all, concern about threats on the | ||
+ | environment by our devices. As previously explained, if modified bacteria with | ||
+ | the cellulase gene are misused or escape, there is a possibility that plants will | ||
+ | have contact with them, creating a possible environmental damage especially | ||
+ | if the affected organisms are ecologically valuable. However, this scenario | ||
+ | is more a concern than a menace, as bacteria need to grow under | ||
+ | specific conditions, and plants themselves have defense mechanisms against | ||
+ | pathogenic microorganisms, so that possibility is greatly diminished. | ||
+ | <br><br> | ||
+ | - security concerns? | ||
+ | <br><br> | ||
+ | No, our project does not posess any danger to security in general, | ||
+ | because the enzymes are designed only to convert sucrose into glucose and | ||
+ | fructose, and cellulose on glucose. Regarding the rest of the devices, the | ||
+ | parts only complement the enzymes to allow them to express and function | ||
+ | properly, so they don’t pose a security threat. | ||
+ | <br><br> | ||
+ | 2. If your response to any of the questions above is yes: | ||
+ | <br><br> | ||
+ | a. Explain how you addressed these issues in project design and while conducting laboratory work. | ||
+ | <br><br> | ||
+ | When designing our project, thanks to the opinion of many professors, | ||
+ | we considered the risks that our device could have because of the enzymes | ||
+ | and the reaction catalyzed. Interestingly enough, the enzymes are already | ||
+ | used in other industries such as food and cleaning industries, so the | ||
+ | measures taken to confine the bacteria were effective in case there was a risk | ||
+ | to the environment or health in general. To accomplish an acceptable safety | ||
+ | level, during the work time at the laboratory, every time bacteria with the | ||
+ | constructs were handled, said work was done inside a laminar flow hood, disinfected before and after being | ||
+ | used. Disposed materials were placed in red bags for biological hazardous | ||
+ | waste, and then sterilized in autoclave. In the end, the material was stored in red | ||
+ | containers so they could be disposed by a certified company. | ||
+ | <br><br> | ||
+ | 3. Under what biosafety provisions will / do you operate? | ||
+ | <br><br> | ||
+ | a. Does your institution have its own biosafety rules and if so | ||
+ | what are they? | ||
+ | <br><br> | ||
+ | Up to this date, there is not a general biosafety handbook for the | ||
+ | university’s laboratories. Nevertheless, we used the handbook provided to us | ||
+ | by the university’s research center, that consists in a handbook for handling | ||
+ | and disposal of hazardous biological waste and a handbook with the | ||
+ | safety rules that must be followed within the lab <a href="https://static.igem.org/mediawiki/2011/d/dd/Laboratory.Rules.pdf">(link)</a> | ||
+ | . Thanks to this, we | ||
+ | were able to take the appropriate safety measures in the academic lab where | ||
+ | we worked along the summer for this project. | ||
+ | <br><br> | ||
+ | b. Does your institution have an Institutional Biosafety Committee | ||
+ | equivalent group? If yes, have you discussed your project with | ||
+ | them?<br> | ||
+ | Describe any concerns or changes that were made based on this | ||
+ | review. | ||
+ | <br><br> | ||
+ | Yes, the university’s research center, “Centro de Biotecnologia | ||
+ | FEMSA”, has a Biosecurity Committee, composed of three doctors from the | ||
+ | institution. All of them received information about our project, the laboratory | ||
+ | protocols that we were using, and the biosafety measures we had; this was | ||
+ | done to have our project checked by them so it could be improved. | ||
+ | The Commitee told us that everything was in order and that we were | ||
+ | following appropriately the measures taken in the university. However, one | ||
+ | of them noted a point that we had overlooked: that the use of cellulase | ||
+ | in a construct could affect the environment because cellulose is the main | ||
+ | component of plants, representing thus a little biosafety concern. For this | ||
+ | reason, the Commitee suggested us to follow the already established | ||
+ | biosafety regulations, to not accidentally free transformed bacteria into the | ||
+ | environment. | ||
+ | <br><br> | ||
+ | c. Will / did you receive any biosafety and/or lab training before | ||
+ | beginning your project? If so, describe this training. | ||
+ | <br><br> | ||
+ | Before initiating the project, some of our team members had already | ||
+ | been to a conference about the laboratory rules that must be followed in the | ||
+ | university’s Research Center, “Centro de Biotecnologia FEMSA”. The rest of | ||
+ | us went to this conference when the project started. In this conference, the | ||
+ | Research Center coordinators provided us with the rules that we had to follow in | ||
+ | those laboratories. The rulebook was adapted to the academic laboratory | ||
+ | where we worked, the Genetic Manipulation and Molecular Diagnosis | ||
+ | Laboratory <a href="https://static.igem.org/mediawiki/2011/d/dd/Laboratory.Rules.pdf">(link)</a>. | ||
+ | Also, Marco Mata, head of the Research Center Safety | ||
+ | Commission, supported us in the biosafety aspect of the project, informing us | ||
+ | about the biosafety measures followed in the Research Center, and allowing | ||
+ | us to take the same measures to our lab to work along the summer. | ||
+ | <br><br> | ||
+ | d. Does your country have national biosafety regulations or | ||
+ | guidelines? | ||
+ | <br><br> | ||
+ | In Mexico, in matters of biosafety, there is a Regulation for the handling | ||
+ | of Hazardous Biological Waste, which we followed to properly dispose all | ||
+ | the waste generated by the project. <a href="http://www.salud.gob.mx/unidades/cdi/nom/087ecolssa.html">(link)</a>. | ||
+ | Moreover, there is a Biosafety Law for | ||
+ | Genetically Modified Organisms <a href="http://www.salud.gob.mx/unidades/cdi/nom/compi/ley180305.html">(link)</a>. | ||
+ | </p> | ||
+ | |||
+ | |||
+ | </div> | ||
+ | <hr> | ||
+ | <br/> | ||
+ | <input type="button" value=" Up " onmouseover="scrollUp()" onmouseout="clearTimeout(t1)"> | ||
+ | <input type="button" value=" Down " onmouseover="scrollDown()" onmouseout="clearTimeout(t1)"> | ||
+ | </div></body></html> |